Key Updates
Palantir declined 4.02% to $135.91 since the May 5 report, extending losses despite delivering record Q1 results with 85% revenue growth and raising full-year guidance. The stock has now fallen 23.54% YTD and 27.67% over six months, breaking below the critical $155 neckline support and approaching the $125 technical level identified in previous analysis. The single new article from CNBC addresses the disconnect between exceptional fundamental performance and continued share price deterioration, suggesting broader market concerns about valuation sustainability and competitive positioning are outweighing near-term operational excellence.
Current Trend
Palantir remains in a confirmed downtrend with YTD losses of 23.54% and six-month declines of 27.67%. The stock is down 35% from its November 2024 peak of $207 and has broken decisively below the $155 neckline support level, now trading at $135.91. All recent timeframes show negative momentum: -6.93% (1-day), -3.73% (5-day), -8.45% (1-month). The stock has violated both its 200-day and 50-week moving averages, with bears maintaining control despite three brief recovery attempts in late April and early May. The current price sits precariously above the $125 support level identified in technical analysis, with further support at $110 and $83 if this level fails.
Investment Thesis
The investment thesis centers on Palantir's exceptional operational execution—achieving a record Rule of 40 score of 145% and 85% revenue growth—against mounting concerns about valuation sustainability and competitive threats from frontier AI models. The company demonstrated $1.5 million revenue per employee with only 70 salespeople, secured a $300 million USDA contract, and raised full-year guidance to $7.65-$7.66 billion. However, Morningstar analysts reduced long-term growth assumptions from 15% to 12% to account for potential AI lab competition, while maintaining a $153 fair value estimate. The thesis now hinges on whether Palantir's ontology platform can defend premium pricing against commoditizing AI capabilities and whether government contract momentum can offset commercial segment underperformance, with U.S. commercial revenue missing expectations despite 133% growth.
Thesis Status
The investment thesis faces significant stress as market action directly contradicts fundamental performance. Despite achieving the highest quarterly revenue growth in company history and raising guidance substantially above consensus, the stock has declined 4.02% since the earnings report and 23.54% YTD. This disconnect suggests investors are pricing in structural risks not captured by current metrics. The thesis degradation is evident in Morningstar's downward revision of long-term growth from 15% to 12% and the stock's persistent weakness despite strong government contract wins and presidential endorsement. The market appears focused on three critical questions: (1) sustainability of 85% growth rates, (2) competitive threats from AI labs like Anthropic mentioned by Michael Burry, and (3) whether current valuation multiples can be justified if growth normalizes toward the revised 12% long-term rate.
Key Drivers
The primary driver is the fundamental disconnect between operational excellence and market valuation concerns. Palantir reported Q1 revenue of $1.63 billion (85% growth) versus $1.54 billion consensus, with adjusted EPS of $0.33 versus $0.28 expected. U.S. revenue reached $1.3 billion with 104% growth, driven by commercial revenue of $595 million (133% growth) and government revenue of $687 million (84% growth). However, U.S. commercial sales fell slightly short of analyst expectations, creating concerns about commercial momentum. The company raised full-year guidance to $7.65-$7.66 billion versus $7.245 billion consensus. Competitive pressure emerged as a key concern, with Morningstar explicitly modeling potential AI lab competition by reducing long-term growth assumptions. The broader software sector selloff, referenced in Bloomberg's analysis, continues to weigh on the stock despite attempts to differentiate performance. Government contracts remain robust, with the Maven Smart System achieving program-of-record status ensuring stable Pentagon funding, as noted in Trump's endorsement.
Technical Analysis
Palantir's technical structure has deteriorated significantly, with the stock breaking below the $155 neckline of a head-and-shoulders pattern and now trading at $135.91, approaching the critical $125 support level. The technical framework identifies major support zones at $155 (broken), $125 (current test zone), $110, and $83, with a measured move target of $75 if support fails comprehensively. The stock trades below both its 200-day and 50-week moving averages, confirming bearish momentum control. A descending triangle formation suggests further downside resolution is likely. With an average post-earnings move of ±14.7%, the current -4.02% decline since the May 5 report remains within historical volatility ranges. The 35% decline from the November 2024 peak of $207 has established a clear downtrend channel. Immediate resistance sits at $155, while a break below $125 would likely trigger accelerated selling toward $110 and potentially $83.
Bull Case
- Record 85% revenue growth with Q1 revenue of $1.63 billion beating consensus $1.54 billion, and raised full-year guidance to $7.65-$7.66 billion versus $7.245 billion analyst expectations, demonstrating exceptional operational momentum (Source)
- All-time high Rule of 40 score of 145% combining revenue growth and operating margin, with industry-leading efficiency of $1.5 million revenue per employee using only 70 salespeople, indicating sustainable profitability expansion (Source)
- U.S. business acceleration with total U.S. revenue of $1.3 billion (104% growth), including commercial revenue of $595 million (133% growth) and government revenue of $687 million (84% growth), showing broad-based domestic demand (Source)
- Strengthened government positioning with Maven Smart System achieving program-of-record status ensuring stable long-term Pentagon funding, $300 million USDA contract, and multibillion-dollar DHS/ICE contracts under Trump administration (Source)
- Morningstar maintains $153 fair value estimate (12.6% upside from current $135.91) and raised five-year average annual growth forecast from 42% to 45%, with analysts assessing AI lab competitive risk as possible but not probable (Source)
Bear Case
- U.S. commercial revenue missed analyst expectations despite 133% growth, indicating potential deceleration in the critical commercial segment that investors are monitoring for sustainable growth beyond government contracts (Source)
- Competitive threat from frontier AI models prompted Morningstar to reduce long-term growth assumptions from 15% to 12%, with Michael Burry claiming Anthropic is "eating Palantir's lunch" and taking a significant short position (Source, Source)
- Technical breakdown with stock down 35% from November 2024 peak of $207, breaking below $155 neckline support and 200-day/50-week moving averages, approaching critical $125 level with measured move target to $75 if support fails (Source)
- Broader software sector selloff creating sustained headwinds, with the stock declining 23.54% YTD and 27.67% over six months despite exceptional earnings, suggesting systematic valuation compression across the sector (Source)
- Market disconnect between fundamental performance and stock price action, with shares declining 4.02% since stellar earnings report, indicating investors are pricing in risks to valuation sustainability and growth normalization not captured by current metrics (Source)